india glp-1 India's weight-loss drug boom: Novo Nordisk talks about generics after patent expiry India GLP-1 Market Shift: Mankind

Typically 46 sessions spaced 12 weeks apart

Clinical trial dosing schedule Standard titration (from Phase 2 trials): Week-by-week escalation: Titration rationale: Reduces side effects (especially nausea) Allows body adaptation to GI effects Gradual weight loss healthier Similar to semaglutide / tirzepatide titration Cannot skip - jumps cause intolerable sides Target doses: 4mg: Minimum effective (17% loss) 8mg: Standard therapeutic (23% loss) 12mg: Maximum approved in trials (24% loss) Higher than 12mg: Not studied, unknown safety Administration: Route: Subcutaneous injection Frequency: Once weekly Location: Abdomen, thigh, or upper arm Timing: Same day each week (consistency) Use our peptide calculator and semaglutide calculator for similar titration planning at SeekPeptides

Some formulations (Wegovy, Saxenda) are also FDA-approved for weight management in adolescents aged 12 years and older

Konstantinos Spaniolas, director of the Stony Brook Bariatric and Metabolic Weight Loss Center, said while Novo's move could force Hims to carry its product, Monday's decision ultimately benefits the patient

Our products are exclusively intended for laboratory research purposes